Model-Informed Radiopharmaceutical Therapy Optimization: A Study on the Impact of PBPK Model Parameters on Physical, Biological, and Statistical Measures in 177Lu-PSMA Therapy. [PDF]
Abdollahi H, Fele-Paranj A, Rahmim A.
europepmc +1 more source
Artificial intelligence for radiopharmaceutical and molecular imaging. [PDF]
Tao J +6 more
europepmc +1 more source
The use of radiopharmaceuticals in targeted cancer therapy: a narrative review. [PDF]
Khalaji A +6 more
europepmc +1 more source
Dynamic PET Imaging of Elesclomol-Facilitated Copper Delivery in Ischemic Stroke Rats. [PDF]
Yuan X +11 more
europepmc +1 more source
Molecular targets and the emerging role of copper radionuclides in prostate cancer theranostics. [PDF]
Rodrigues D +4 more
europepmc +1 more source
Diagnosis and treatment of paragangliomas and pheochromocytomas: a survey from the Italian Association for Neuroendocrine Tumors. [PDF]
Pietroluongo E +10 more
europepmc +1 more source
Impact of prolonged use of NSAID (Diclofenac) on 99mTc-MAG3 and 99mTc-DTPA renography. [PDF]
Mustafa S, Elgazzar A.
europepmc +1 more source
Prostate Cancer-Research Advances in Early Detection. [PDF]
Czerw A +28 more
europepmc +1 more source
Exploring the Therapeutic Potential of <sup>177</sup>Lu-PSMA-617 in a Mouse Model of Prostate Cancer Bone Metastases. [PDF]
Peng CL, Chen CT, Tang IC.
europepmc +1 more source
Do we need dosimetry for the optimization of theranostics in CNS tumors? [PDF]
Cicone F +9 more
europepmc +1 more source

